Skip to content

Oramed Pharmaceuticals Inc Sustainability Reports

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of oral drug delivery systems. The company specializes in converting injectable therapeutic proteins, such as insulin, into oral formulations utilizing a proprietary technology platform.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299006K52ZIIGQJ6R84

FIGI: BBG001SK4M90

9 reports from 2009 to 2025